BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17448526)

  • 41. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
    Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
    J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
    Gerken TA; Jamison O; Perrine CL; Collette JC; Moinova H; Ravi L; Markowitz SD; Shen W; Patel H; Tabak LA
    J Biol Chem; 2011 Apr; 286(16):14493-507. PubMed ID: 21349845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.
    Argüeso P; Tisdale A; Mandel U; Letko E; Foster CS; Gipson IK
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):86-92. PubMed ID: 12506059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
    Cheng L; Tachibana K; Iwasaki H; Kameyama A; Zhang Y; Kubota T; Hiruma T; Tachibana K; Kudo T; Guo JM; Narimatsu H
    FEBS Lett; 2004 May; 566(1-3):17-24. PubMed ID: 15147861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.
    Rambaruth ND; Greenwell P; Dwek MV
    Glycobiology; 2012 Jun; 22(6):839-48. PubMed ID: 22322011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation.
    Zlocowski N; Sendra VG; Lorenz V; Villarreal MA; Jorge A; Núñez Y; Bennett EP; Clausen H; Nores GA; Irazoqui FJ
    Biochem Biophys Res Commun; 2011 Jun; 410(1):140-5. PubMed ID: 21651894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoform-specific regulation of osteogenic factors by polypeptide N-Acetylgalactosaminyltransferases 1 and 4.
    Tang J; Zheng H; Chen L; Gao S; Shi X; Liu J; Xu L
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1449-1454. PubMed ID: 27965094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
    Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
    J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen.
    Rivinoja A; Kokkonen N; Kellokumpu I; Kellokumpu S
    J Cell Physiol; 2006 Jul; 208(1):167-74. PubMed ID: 16547942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional control of polypeptide GalNAc-transferase 3 through an acetylation site in the C-terminal lectin domain.
    Lorenz V; Cejas RB; Bennett EP; Nores GA; Irazoqui FJ
    Biol Chem; 2017 Oct; 398(11):1237-1246. PubMed ID: 28672761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
    Gomes J; Marcos NT; Berois N; Osinaga E; Magalhães A; Pinto-de-Sousa J; Almeida R; Gärtner F; Reis CA
    J Histochem Cytochem; 2009 Jan; 57(1):79-86. PubMed ID: 18854599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The polypeptide N-acetylgalactosaminyltransferase 4 exhibits stage-dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation.
    Yan X; Lu J; Zou X; Zhang S; Cui Y; Zhou L; Liu F; Shan A; Lu J; Zheng M; Feng B; Zhang Y
    FEBS J; 2018 Aug; 285(16):3041-3055. PubMed ID: 29931806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family.
    Young WW; Holcomb DR; Ten Hagen KG; Tabak LA
    Glycobiology; 2003 Jul; 13(7):549-57. PubMed ID: 12651884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2.
    Liu J; Yang L; Jin M; Xu L; Wu S
    Mol Med Rep; 2011; 4(6):1299-305. PubMed ID: 21874244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation.
    Shan A; Lu J; Xu Z; Li X; Xu Y; Li W; Liu F; Yang F; Sato T; Narimatsu H; Zhang Y
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):870-882. PubMed ID: 30797803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.
    Banford S; Timson DJ
    Curr Cancer Drug Targets; 2017; 17(1):53-61. PubMed ID: 27659430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase family is spatially and temporally regulated during Drosophila development.
    Tian E; Ten Hagen KG
    Glycobiology; 2006 Feb; 16(2):83-95. PubMed ID: 16251381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase with an unusual lectin domain from the platyhelminth parasite Echinococcus granulosus.
    Freire T; Fernández C; Chalar C; Maizels RM; Alzari P; Osinaga E; Robello C
    Biochem J; 2004 Sep; 382(Pt 2):501-10. PubMed ID: 15142032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.